MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Yaddanapudi K, Rendon BE, Lamont G, Kim EJ, Al Rayyan N, Richie J, Albeituni S, Waigel S, Wise A, Mitchell RA.
Yaddanapudi K, et al. Among authors: al rayyan n.
Cancer Immunol Res. 2016 Feb;4(2):101-12. doi: 10.1158/2326-6066.CIR-15-0070-T. Epub 2015 Nov 24.
Cancer Immunol Res. 2016.
PMID: 26603621
Free PMC article.